RESULTS
Study enrollment started on December 21, 2021 and the estimated completion of the primary assessments is June 2025. To date, January 2, 2023, a total of 18 patients have been enrolled in the study. Three patients have completed the 1‐year follow‐up. The baseline characteristics of the patients currently enrolled are shown in Supporting Information: Table 